PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
Clinical trial NCT02187250 · COMPLETED
Trial details
- NCT number
- NCT02187250
- Sponsor
- University Medical Centre Ljubljana
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-06-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.